Pathoquest, A Charles River Company, is a global CRO specializing in NGS-based Biosafety Quality Control through its iDTECT® assay platform, enabling the rapid and safe release of biotherapies to patients. The company offers validated GMP assays for viral safety testing and genetic characterization of raw materials, cell and gene therapies, monoclonal antibodies, and vaccines. Our testing services are available from facilities located in Paris, France, and Wayne, Pennsylvania. Your GMP Next-Gen Biosafety Partner. Compliant, Faster, Animal-Free.
Looking for a particular PathoQuest employee's phone or email?
The PathoQuest annual revenue was $9 million in 2026.
Guillaume Deplaine is the COO of PathoQuest.
48 people are employed at PathoQuest.
PathoQuest is based in Paris, Ile-de-France.
The NAICS codes for PathoQuest are [5417, 541, 54, 54171, 541713].
The SIC codes for PathoQuest are [87, 873].